4//SEC Filing
Dietz Thomas John 4
Accession 0001140361-22-047071
CIK 0001305253other
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 5:31 PM ET
Size
4.7 KB
Accession
0001140361-22-047071
Insider Transaction Report
Form 4
Dietz Thomas John
Director
Transactions
- Sale
Common Stock
2022-12-22$1.17/sh−22,500$26,303→ 21,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.1628 to $1.175, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001574218
Filing Metadata
- Form type
- 4
- Filed
- Dec 26, 7:00 PM ET
- Accepted
- Dec 27, 5:31 PM ET
- Size
- 4.7 KB